Literature DB >> 28855232

Molecular mechanisms of inflammasome signaling.

Anukriti Mathur1, Jenni A Hayward1, Si Ming Man1.   

Abstract

The inflammasome is a macromolecular protein complex that mediates proteolytic cleavage of pro-IL-1β and -IL-18 and induces cell death in the form of pyroptosis. Certain nucleotide-binding oligomerization domain-like receptors (NLRs), absent in melanoma 2 (AIM2)-like receptors (ALRs), or tripartite motif (TRIM) family receptors trigger the assembly of an inflammasome in response to pathogen-associated molecular patterns (PAMPs) or danger-associated molecular patterns (DAMPs). Recent studies have revealed a multitude of host components and signals that are essential for controlling canonical and noncanonical inflammasome activation and pyroptosis. These include pore-forming gasdermin proteins, the never in mitosis A-related kinase 7 (NEK7), IFN-inducible proteins (IFIs), reactive oxygen species (ROS), autophagy, potassium efflux, mitochondrial perturbations, and microbial metabolites. Here, we provide a comprehensive overview of the molecular and signaling mechanisms that provide stringent regulation over the activation and effector functions of the inflammasome. ©2017 Society for Leukocyte Biology.

Entities:  

Keywords:  AIM2; NLRC4; NLRP1/3; Pyrin; caspases

Mesh:

Substances:

Year:  2017        PMID: 28855232     DOI: 10.1189/jlb.3MR0617-250R

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  63 in total

Review 1.  Activated protein C in neuroprotection and malaria.

Authors:  Laurent O Mosnier
Journal:  Curr Opin Hematol       Date:  2019-09       Impact factor: 3.284

Review 2.  Molecular mechanisms of phenotypic variability in monogenic autoinflammatory diseases.

Authors:  Ivona Aksentijevich; Oskar Schnappauf
Journal:  Nat Rev Rheumatol       Date:  2021-05-25       Impact factor: 20.543

3.  IRGM1, a guardian of mitochondrial DAMP-mediated autoinflammation.

Authors:  Brett A Kaufman; Ana L Mora
Journal:  Nat Immunol       Date:  2021-03       Impact factor: 25.606

Review 4.  NLRP3 inflammasome in cancer and metabolic diseases.

Authors:  Bhesh Raj Sharma; Thirumala-Devi Kanneganti
Journal:  Nat Immunol       Date:  2021-03-11       Impact factor: 25.606

Review 5.  Inflammasomes: Their Role in Normal and Complicated Pregnancies.

Authors:  Nardhy Gomez-Lopez; Kenichiro Motomura; Derek Miller; Valeria Garcia-Flores; Jose Galaz; Roberto Romero
Journal:  J Immunol       Date:  2019-12-01       Impact factor: 5.422

Review 6.  Reconciling protective and pathogenic roles of the NLRP3 inflammasome in leishmaniasis.

Authors:  Valerie Harrington; Prajwal Gurung
Journal:  Immunol Rev       Date:  2020-06-20       Impact factor: 12.988

Review 7.  Functional crosstalk between non-canonical caspase-11 and canonical NLRP3 inflammasomes during infection-mediated inflammation.

Authors:  Young-Su Yi
Journal:  Immunology       Date:  2019-11-10       Impact factor: 7.397

8.  Adenosine Triphosphate Release is Required for Toll-Like Receptor-Induced Monocyte/Macrophage Activation, Inflammasome Signaling, Interleukin-1β Production, and the Host Immune Response to Infection.

Authors:  Albert H Lee; Carola Ledderose; Xiaoou Li; Christian J Slubowski; Koichiro Sueyoshi; Laura Staudenmaier; Yi Bao; Jingping Zhang; Wolfgang G Junger
Journal:  Crit Care Med       Date:  2018-12       Impact factor: 7.598

9.  Malassezia spp. induce inflammatory cytokines and activate NLRP3 inflammasomes in phagocytes.

Authors:  Andrea J Wolf; Jose J Limon; Christopher Nguyen; Alexander Prince; Anthony Castro; David M Underhill
Journal:  J Leukoc Biol       Date:  2020-09-17       Impact factor: 4.962

10.  Phenotypical and Functional Characterization of Neutrophils in Two Pyrin-Associated Auto-inflammatory Diseases.

Authors:  Bert Malengier-Devlies; Mieke Metzemaekers; Mieke Gouwy; Erika Van Nieuwenhove; Albrecht Betrains; Maaike Cockx; Lotte Vanbrabant; Noëmie Pörtner; Jurgen Vercauteren; Lien De Somer; Sofie Struyf; Steven Vanderschueren; Ellen De Langhe; Paul Proost; Patrick Matthys; Carine Wouters
Journal:  J Clin Immunol       Date:  2021-03-05       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.